May 10, 2025 - 06:09

In a recent episode of the podcast, Dr. Ted Wright, a renowned cardiothoracic surgeon, delves into the innovative approach of Hybrid Afib Therapy. This cutting-edge treatment combines surgical and catheter-based techniques to address atrial fibrillation, a common heart rhythm disorder that affects millions worldwide.
Dr. Wright discusses the complexities of Afib and the challenges patients face when seeking effective treatment options. He explains how Hybrid Afib Therapy offers a comprehensive solution by integrating both surgical and minimally invasive methods, potentially leading to better outcomes for patients.
Listeners will gain insight into the procedural aspects of the therapy, the benefits it provides, and the importance of individualized treatment plans. Dr. Wright also emphasizes the role of patient education and shared decision-making in achieving optimal results. This episode serves as a valuable resource for anyone looking to understand more about advancements in cardiac care and the future of Afib treatments.
May 28, 2026 - 03:00
Colorectal cancer risk linked to gut microbiome alterations | Harvard T.H. Chan School of Public HealthEven more than ten years after a precancerous growth called an adenoma is removed from the colon, the gut microbiome and its related metabolites may still show lasting changes that increase the...
May 27, 2026 - 14:17
A Great Athlete is a Healthy Athlete: Muaz’s Journey to Becoming a Fitness CaptainEvery May, Special Olympics marks Fitness and Sport Month, a time to highlight how physical activity boosts health, performance, and overall well-being for athletes. This year, I sat down with Muaz...
May 26, 2026 - 20:41
Popular fruit may help protect your skin from the sun, new study suggestsA new study suggests that eating grapes might offer a natural layer of protection against the sun`s harmful rays. Published in the journal ACS Nutrition Science, the research indicates that...
May 26, 2026 - 16:16
Optima Health Leads These 3 Undiscovered Gems in the United KingdomAs the FTSE 100 and FTSE 250 struggle under pressure from weak global signals and disappointing trade numbers out of China, many investors are shifting their attention away from big-name blue chips...